News related to Bicalutamide and/or conditions it is approved for
Utility And Health-Related Quality Of Life In Prostate Cancer Patients 12 Months After Radical Prostatectomy Or Radiation Therapy
Source: Health News from Medical News Today [2010.03.18]
UroToday.com - The most common curative treatments for localized prostate cancer (PC), radical prostatectomy (RP) and radiation therapy (RT), have significant effects on quality of life. Most studies measured quality of life using psychometric instruments. Another approach uses the concept of utility. Utility is a global measure, scaled between 0 (dead) and 1 (full health), which reflects not only symptoms or feelings, but also patients' values or preferences for them...
Insufficiency Fractures After Pelvic Radiotherapy In Patients With Prostate Cancer
Source: Bones / Orthopedics News From Medical News Today [2010.03.18]
UroToday.com - In this study, we reported our experience with sacral insufficiency fractures (IF) in patients with prostate cancer who underwent pelvic radiotherapy as part of their definitive treatment. Insufficiency fractures are considered a rare complication of radiotherapy. IF has been described after irradiation for gynaecologic, anal, and rectal cancer...
Interventional Radiology Treatments For Recurrent Prostate Cancer
Source: MRI / PET / Ultrasound News From Medical News Today [2010.03.17]
The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa...
Therapeutic Potential Of Adult Bone Marrow-Derived Mesenchymal Stem Cells In Prostate Cancer Bone Metastasis
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.17]
UroToday.com - Adult bone marrow-derived mesenchymal stem cells (MSC) have been shown to inhibit tumor growth in various studies. Although MSC express MHC class I molecules, they lack expression of co-stimulatory molecules and suppress T-cell response, which gives them the utility to overcome a wide range of immunologic barriers...
Prostate Cancer Radiation Side Effects May Subside With Time
Source: MedicineNet Cancer Specialty [2010.03.17]
Title: Prostate Cancer Radiation Side Effects May Subside With Time
Category: Health News
Created: 3/16/2010 12:10:00 PM
Last Editorial Review: 3/17/2010
Prostate Cancer Radiation Side Effects May Subside With
Time (HealthDay)
Source: Y! Health Prostate Cancer News [2010.03.16]
HealthDay - TUESDAY, March 16 (HealthDay News) -- The balance between using
enough radiation to shield patients from prostate cancer's return while
keeping side effects at bay may not be as tricky as once thought, new
research shows.
Genentech Provides Update On Phase III Study Of Avastin In Men With Late Stage Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.14]
Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the topline results of a Phase III trial led by the U.S...
Researchers Develop Tool To Help Study Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.13]
Van Andel Research Institute (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer. Using the model, they found that normal cells and cancer cells depend on different factors to survive, which could aid in discovering how to target cancer cells without affecting normal cells when developing treatments...
Growing doubts over standard prostate cancer test (AFP)
Source: Y! Health Prostate Cancer News [2010.03.13]
AFP - The most commonly used prostate cancer screening procedure, PSA, is at the center of a growing debate after its discoverer said it had become a "hugely expensive public health disaster."
Abbott Seeks FDA Approval Of A New Six-Month 45-mg Formulation Of Lupron(R) Depot For The Palliative Treatment Of Advanced Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.12]
The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental new drug application (sNDA) of a new six-month 45-mg formulation of Lupron® Depot (leuprolide acetate for depot suspension) for use in the palliative treatment of advanced prostate cancer. Palliative treatment helps to relieve symptoms associated with advanced prostate cancer...
PSA Test Reduces Prostate Cancer Deaths By 40%
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.12]
When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story...
Can Multimedia Lead To More Informed Decisions On Prostate Cancer Treatment?
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.12]
Mount Sinai School of Medicine is leading a study of patients newly-diagnosed with prostate cancer to determine if providing them with multimedia materials can help them make more informed treatment decisions. Michael Diefenbach, Ph.D...
AdMeTech Hails New Research That Shows Promise Of MRI To Discriminate Aggressive Prostate Cancer From Dormant Disease
Source: MRI / PET / Ultrasound News From Medical News Today [2010.03.11]
New preliminary data from a pilot study in the Netherlands indicates that imaging tools may help address the most challenging clinical dilemma of prostate cancer care as identified by the hearing of the House Oversight and Government Reform Committee and its expert witnesses last week: to treat or not treat, AdMeTech Foundation's President and CEO Dr. Faina Shtern said today...
Identifying Patient-Relevant Outcomes In Metastatic Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.11]
While subjective patient-reported outcomes, such as scores from health-status questionnaires, have become an integral part of clinical trials, there is also a need to identify what specific outcomes are the most important ones to target in a given disease context...
First Inherited Prostate Cancer Genetic Mutation Found In African-American Men
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.11]
Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease. Dr...
Reovirus May Be A Novel Approach To Prostate Cancer Treatment
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.10]
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research...
Doctor's Specialty Often Steers Prostate Cancer Care
Source: MedicineNet Hormone Therapy Specialty [2010.03.10]
Title: Doctor's Specialty Often Steers Prostate Cancer Care
Category: Health News
Created: 3/9/2010 2:10:00 PM
Last Editorial Review: 3/10/2010
Dietary Supplements Discouraged For Prostate Cancer Patients
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.09]
Prostate-specific dietary supplements should not be taken during radiation therapy treatments because they have been shown to increase the radiosensitivity of normal prostate cell lines, leading to normal tissue complications, according to a study in the March issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society ...
Prostate Cancer Therapy Correlates To Specialist Seen
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.09]
New research published in today's issue of the Archives of Internal Medicine (Vol. 170, No. 5), by an investigator at The Cancer Institute of New Jersey (CINJ) and colleagues at Memorial Sloan-Kettering Cancer Center in New York, shows that the type of specialist that men with localized prostate cancer see can influence the form of therapy they ultimately receive...
Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study Of Picoplatin In Metastatic Prostate Cancer
Source: Conferences News From Medical News Today [2010.03.06]
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC)...
New Guidelines for Prostate Cancer Screening
Source: MedicineNet Impotence (ED) Specialty [2010.03.05]
Title: New Guidelines for Prostate Cancer Screening
Category: Health News
Created: 3/5/2010 10:32:00 AM
Last Editorial Review: 3/5/2010 10:32:26 AM
New Drug Fights Advanced Prostate Cancer
Source: MedicineNet Aches, Pain, Fever Specialty [2010.03.04]
Title: New Drug Fights Advanced Prostate Cancer
Category: Health News
Created: 3/4/2010 11:09:00 AM
Last Editorial Review: 3/4/2010 11:09:45 AM
New Prostate Cancer Screening Guidelines Unveiled
Source: MedicineNet Impotence (ED) Specialty [2010.03.04]
Title: New Prostate Cancer Screening Guidelines Unveiled
Category: Health News
Created: 3/3/2010 12:10:00 PM
Last Editorial Review: 3/4/2010
Effective Prostate Cancer Treatment Discovery
Source: Endocrinology News From Medical News Today [2010.02.27]
Monash University biomedical scientists have identified a new way to treat castrate resistant cells in prostate cancer sufferers - the most common cancer in Australian men. For more than 60 years the main way to treat men with prostate cancer has involved removing the hormones that fuel growth of the cancer cells...
Statins May Benefit Prostate Cancer Patients
Source: MedicineNet Statins Specialty [2010.02.23]
Title: Statins May Benefit Prostate Cancer Patients
Category: Health News
Created: 2/22/2010 4:10:00 PM
Last Editorial Review: 2/23/2010
Prostate Cancer Diagnosis Raises Suicide Risk
Source: MedicineNet Colon Cancer Specialty [2010.02.03]
Title: Prostate Cancer Diagnosis Raises Suicide Risk
Category: Health News
Created: 2/2/2010 6:10:00 PM
Last Editorial Review: 2/3/2010
Sexual Function Does Not Continuously Decline After Radiation Therapy Treatments For Prostate Cancer
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2010.01.07]
Sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first two years after treatment but then stabilizes and does not continuously decline as was previously thought, according to a study in the January 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American So...
Experimental Drug May Help in Brain, Prostate Cancers
Source: MedicineNet Leukemia Specialty [2010.01.05]
Title: Experimental Drug May Help in Brain, Prostate Cancers
Category: Health News
Created: 1/4/2010 2:10:00 PM
Last Editorial Review: 1/5/2010
Beer Ingredient Eyed in Prostate Cancer Prevention
Source: MedicineNet finasteride Specialty [2009.12.09]
Title: Beer Ingredient Eyed in Prostate Cancer Prevention
Category: Health News
Created: 12/9/2009 8:10:00 AM
Last Editorial Review: 12/9/2009
Hormonal Drugs Cool Hot Flashes From Prostate Cancer Therapy
Source: MedicineNet medroxyprogesterone Specialty [2009.12.07]
Title: Hormonal Drugs Cool Hot Flashes From Prostate Cancer Therapy
Category: Health News
Created: 12/6/2009 6:10:00 PM
Last Editorial Review: 12/7/2009
New Test Checks for Prostate Cancer Return
Source: MedicineNet Prostate Specific Antigen Specialty [2009.10.20]
Title: New Test Checks for Prostate Cancer Return
Category: Health News
Created: 10/20/2009 11:07:00 AM
Last Editorial Review: 10/20/2009 11:07:22 AM
STD Linked to Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2009.09.14]
Title: STD Linked to Prostate Cancer
Category: Health News
Created: 9/14/2009 11:22:00 AM
Last Editorial Review: 9/14/2009 11:22:01 AM
Prostate Cancer Over-Diagnosed: Study
Source: MedicineNet Urinary Incontinence Specialty [2009.09.01]
Title: Prostate Cancer Over-Diagnosed: Study
Category: Health News
Created: 8/31/2009 4:10:00 PM
Last Editorial Review: 9/1/2009
Green Tea Component May Slow Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2009.06.22]
Title: Green Tea Component May Slow Prostate Cancer
Category: Health News
Created: 6/20/2009 7:00:00 AM
Last Editorial Review: 6/22/2009
Prostate Cancer Vaccine Meets Goal
Source: MedicineNet Tremor Specialty [2009.04.15]
Title: Prostate Cancer Vaccine Meets Goal
Category: Health News
Created: 4/15/2009
Last Editorial Review: 4/15/2009
Drug May Help Prevent Prostate Cancer
Source: MedicineNet finasteride Specialty [2009.02.25]
Title: Drug May Help Prevent Prostate Cancer
Category: Health News
Created: 2/25/2009
Last Editorial Review: 2/25/2009
Prostate Cancer Therapy May Not Help
Source: MedicineNet leuprolide Specialty [2008.07.09]
Title: Prostate Cancer Therapy May Not Help
Category: Health News
Created: 7/9/2008
Last Editorial Review: 7/9/2008
Prostate Cancer
Source: MedicineNet Hydronephrosis Specialty [2007.06.04]
Title: Prostate Cancer
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 6/4/2007
Lifestyle, diet may stop or reverse prostate cancer progression
Source: The Doctors Lounge - Urology
The research is the first randomized, controlled trial to show that lifestyle changes may affect cancer progression.
RNA Quality In Fresh Frozen Prostate Tissue From Patients Operated With Radical Prostatectomy
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.17]
UroToday.com - Discovery of new genes that may be biomarkers for prostate cancer (CaP) often are identified by microarray analysis of RNA obtained from radical prostatectomy tissue. In the Scandinavian Journal of Clinical and Laboratory Investigation, Dr. Helena Bertilsson and colleagues analyze what variables impact RNA quality and ultimately lead to the discovery of biomarkers from CaP tissue...
Scientists Find Key to Hormone-Resistant Prostate Tumors (HealthDay)
Source: Y! Health News Search RSS Feed [2010.03.10]
HealthDay - WEDNESDAY, March 10 (HealthDay News) -- Though hormone therapy
has proven useful in treating late-stage prostate cancer, it often results
in the development of fatal secondary tumors that are resistant to such
therapy.
Prostate test 'public health disaster': discoverer (Reuters)
Source: Y! Health Prostate Cancer News [2010.03.10]
Reuters - The most commonly used tool for detecting prostate cancer, routine PSA screening, has become "a hugely expensive public health disaster," its discoverer said on Wednesday.
PROGENSA(R) PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented At Leading Medical Meeting Confirm
Source: Conferences News From Medical News Today [2010.03.09]
Gen-Probe's (Nasdaq: GPRO) PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco...
Millennium Announces First Clinical Data For TAK-700 Prostate Molecule At ASCO GU
Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.09]
Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cancer (mCRPC)...
ASCO GU: Novel Retrovirus Mimics HIV Transmission
Source: MedPage Today Infectious Disease [2010.03.06]
SAN FRANCISCO (MedPage Today) -- A novel retrovirus implicated in prostate cancer appears to be transmitted much the way HIV is, researchers found.
Penile Length Shortening After Radical Prostatectomy: Men's Responses
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.12.06]
UroToday.com - Erectile dysfunction is the most commonly recognized side effect of radical prostatectomy (RP) for prostate cancer (CaP). However, post-surgery penile length shortening (PLS) is known to occur in up to three-fourths of men. The impact of PLS has not previously been assessed...
|
